About
Technology
Issues
FAQ
Links
Official Page
Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.